Grantham, Mayo, Van Otterloo & Co (GMO)’s Tenet Healthcare THC Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,500	Closed	-$435K	–	764
2021 Q2	$435K	Buy	+6,500	New	+$403K	﹤0.01%	633
2021 Q1	–	Sell	-49,138	Closed	-$1.96M	–	935
2020 Q4	$1.96M	Sell	49,138 -62,152	-56%	-$2.01M	0.01%	446
2020 Q3	$2.73M	Buy	+111,290	New	+$2.84M	0.02%	356
2020 Q1	–	Sell	-33,800	Closed	-$1.28M	–	821
2019 Q4	$1.28M	Buy	+33,800	New	+$1.01M	0.01%	476
2019 Q1	–	Sell	-118,599	Closed	-$2.03M	–	745
2018 Q4	$2.03M	Hold	118,599	–	–	0.02%	277
2018 Q3	$3.38M	Hold	118,599	–	–	0.02%	252
2018 Q2	$3.98M	Sell	118,599 -54,762	-32%	-$1.7M	0.03%	240
2018 Q1	$4.2M	Sell	173,361 -65,539	-27%	-$1.3M	0.03%	246
2017 Q4	$3.62M	Hold	238,900	–	–	0.02%	268
2017 Q3	$3.92M	Sell	238,900 -48,500	-17%	-$822K	0.02%	250
2017 Q2	$5.56M	Hold	287,400	–	–	0.03%	231
2017 Q1	$5.09M	Buy	+287,400	New	+$5.33M	0.03%	233
2014 Q1	–	Sell	-11,743	Closed	-$495K	–	636
2013 Q4	$495K	Sell	11,743 -8,295	-41%	-$361K	﹤0.01%	546
2013 Q3	$825K	Sell	20,038 -3,070	-13%	-$128K	﹤0.01%	475
2013 Q2	$1.06M	Buy	+23,108	New	+$1.03M	﹤0.01%	455

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Centerbridge Partners New York $38.1M AUM 9.24% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s THC Position: Q3 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Tenet Healthcare (THC) in Q3 2021, closing a stake of 6,500 shares — an estimated $435K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in THC in Q2 2013 and held it in 15 quarters. The position peaked at $5.56M in Q2 2017. 336 funds tracked by Wall St. Rank hold THC as of Q3 2021.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Tenet Healthcare position as of Q3 2021 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 6,500 Tenet Healthcare shares in Q3 2021, an estimated $435K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Tenet Healthcare in Q2 2013 and held it in 15 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Tenet Healthcare position peaked at $5.56M in Q2 2017.
336 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2021, filed 12 Nov 2021.